William Blair & Company
AMED

William Blair & Company’s Amedisys AMED Stock Holding History

William Blair & Company’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,814
Closed -$657K – 1861
2022
Q1 		$657K Sell
3,814
-52
-1% -$7.77K ﹤0.01% 1061
2021
Q4 		$626K Buy
3,866
+42
+1% +$6.75K ﹤0.01% 1128
2021
Q3 		$570K Sell
3,824
-10,855
-74% -$2.26M ﹤0.01% 1109
2021
Q2 		$3.6M Sell
14,679
-870
-6% -$228K 0.01% 541
2021
Q1 		$4.12M Sell
15,549
-4,141
-21% -$1.17M 0.02% 498
2020
Q4 		$5.78M Buy
19,690
+13
+0.1% +$3.33K 0.02% 408
2020
Q3 		$4.65M Buy
19,677
+1,138
+6% +$259K 0.02% 415
2020
Q2 		$3.68M Sell
18,539
-39
-0.2% -$7.27K 0.02% 444
2020
Q1 		$3.41M Buy
18,578
+336
+2% +$59.8K 0.02% 409
2019
Q4 		$3.04M Buy
18,242
+13,147
+258% +$1.96M 0.02% 509
2019
Q3 		$667K Sell
5,095
-2,202
-30% -$287K ﹤0.01% 861
2019
Q2 		$886K Buy
7,297
+1,780
+32% +$211K 0.01% 791
2019
Q1 		$680K Buy
+5,517
New +$692K ﹤0.01% 858
2017
Q3 		– Sell
-25,887
Closed -$1.63M – 1365
2017
Q2 		$1.63M Sell
25,887
-344
-1% -$20K 0.01% 622
2017
Q1 		$1.34M Buy
26,231
+529
+2% +$25.2K 0.01% 632
2016
Q4 		$1.1M Buy
25,702
+4,537
+21% +$193K 0.01% 634
2016
Q3 		$1M Buy
21,165
+165
+0.8% +$8.23K 0.01% 645
2016
Q2 		$1.06M Sell
21,000
-3,895
-16% -$197K 0.01% 622
2016
Q1 		$1.2M Buy
+24,895
New +$961K 0.01% 572

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

William Blair & Company's AMED Position: Q2 2022 in Review

William Blair & Company sold out of Amedisys (AMED) in Q2 2022, closing a stake of 3,814 shares — an estimated $657K sold.

William Blair & Company first reported a position in AMED in Q1 2016 and held it in 19 quarters. The position peaked at $5.78M in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

  • William Blair & Company reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
  • William Blair & Company sold 3,814 Amedisys shares in Q2 2022, an estimated $657K.
  • William Blair & Company first reported a position in Amedisys in Q1 2016 and held it in 19 quarters.
  • William Blair & Company's Amedisys position peaked at $5.78M in Q4 2020.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on William Blair & Company's 13F filing for Q2 2022, filed 10 Aug 2022.